US Stock MarketDetailed Quotes

FGEN FibroGen

Watchlist
  • 0.348
  • -0.097-21.80%
Close Mar 18 16:00 ET
  • 0.350
  • +0.002+0.57%
Post 20:01 ET
35.12MMarket Cap-0.73P/E (TTM)

About FibroGen Company

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Company Profile

SymbolFGEN
Company NameFibroGen
Listing DateNov 14, 2014
Issue Price18.00
Founded1993
CEOMr. Thane Wettig
MarketNASDAQ
Employees486
Fiscal Year Ends12-31
Address350 Bay Street,Suite 100-6009
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94133
Phone1-415-978-1200

Company Executives

  • Name
  • Position
  • Salary
  • Thane Wettig
  • Chief Executive Officer and Director
  • 3.64M
  • David DeLucia
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Christine Chung
  • Senior Vice President, China Operations
  • 3.11M
  • James A. Schoeneck
  • Chairman of the Board
  • 499.58K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 375.53K
  • Jeffrey L. Edwards
  • Independent Director
  • 385.53K
  • Dr. Aoife M. Brennan, M.B.
  • Independent Director
  • 373.03K
  • Jeffrey W. Henderson
  • Independent Director
  • 370.53K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati Show More